China
# |
Name |
EBIT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
44.84%
|
Dec. 31, 2023 | USD 7.81 | 1.73% |
|
China |
|
2 |
43.78%
|
Dec. 31, 2023 | USD 1.85 | -1.20% |
|
China |
|
3 |
43.51%
|
Dec. 31, 2023 | USD 2.78 | -1.27% |
|
China |
|
4 |
42.22%
|
Dec. 31, 2023 | USD 2.35 | 0.02% |
|
China |
|
5 |
41.46%
|
Dec. 31, 2023 | USD 2.68 | -1.51% |
|
China |
|
6 |
39.63%
|
Dec. 31, 2023 | USD 2.18 | 0.29% |
|
China |
|
7 |
37.93%
|
Dec. 31, 2023 | USD 2.28 | 1.94% |
|
China |
|
8 |
36.69%
|
Dec. 31, 2023 | USD 7.07 | -1.23% |
|
China |
|
9 |
35.33%
|
Dec. 31, 2023 | USD 3.70 | -0.36% |
|
China |
|
10 |
34.79%
|
Dec. 31, 2023 | USD 2.88 | 0.58% |
|
China |
|
11 |
34.32%
|
Dec. 31, 2023 | USD 3.80 | 1.71% |
|
China |
|
12 |
32.41%
|
Dec. 31, 2023 | USD 3.08 | 0.94% |
|
China |
|
13 |
31.13%
|
Dec. 31, 2023 | USD 3.06 | -1.56% |
|
China |
|
14 |
30.32%
|
Dec. 31, 2023 | USD 1.98 | -1.19% |
|
China |
|
15 |
29.67%
|
Dec. 31, 2023 | USD 0.47 | 3.66% |
|
China |
|
16 |
28.03%
|
Dec. 31, 2023 | USD 0.77 | -3.24% |
|
China |
|
17 |
27.68%
|
Dec. 31, 2023 | USD 0.96 | 0.77% |
|
China |
|
18 |
27.50%
|
Dec. 31, 2023 | USD 2.34 | -1.60% |
|
China |
|
19 |
25.59%
|
Dec. 31, 2023 | USD 9.39 | -0.63% |
|
China |
|
20 |
25.21%
|
Dec. 31, 2023 | USD 2.45 | -0.43% |
|
China |
|
21 |
25.03%
|
Dec. 31, 2023 | USD 0.99 | 4.41% |
|
China |
|
22 |
24.87%
|
Dec. 31, 2023 | USD 3.68 | -0.21% |
|
China |
|
23 |
23.39%
|
Dec. 31, 2023 | USD 2.03 | -0.16% |
|
China |
|
24 |
22.05%
|
Dec. 31, 2023 | USD 4.81 | -0.80% |
|
China |
|
25 |
20.70%
|
Dec. 31, 2023 | USD 0.84 | -0.59% |
|
China |
|
26 |
20.50%
|
Dec. 31, 2023 | USD 3.39 | 4.94% |
|
China |
|
27 |
19.99%
|
Dec. 31, 2023 | USD 3.38 | -0.40% |
|
China |
|
28 |
19.61%
|
Dec. 31, 2023 | USD 0.91 | 1.13% |
|
China |
|
29 |
18.44%
|
Dec. 31, 2023 | USD 6.71 | 0.24% |
|
China |
|
30 |
17.81%
|
Dec. 31, 2023 | USD 3.32 | -1.00% |
|
China |
|
31 |
16.58%
|
Dec. 31, 2023 | USD 2.15 | -0.48% |
|
China |
|
32 |
16.35%
|
Dec. 31, 2023 | USD 1.35 | 1.98% |
|
China |
|
33 |
15.61%
|
Dec. 31, 2023 | USD 1.70 | 0.39% |
|
China |
|
34 |
15.36%
|
Dec. 31, 2023 | USD 1.92 | -0.31% |
|
China |
|
35 |
15.10%
|
Dec. 31, 2023 | USD 1.54 | -1.68% |
|
China |
|
36 |
15.00%
|
Dec. 31, 2023 | USD 11.02 | -1.67% |
|
China |
|
37 |
14.45%
|
Dec. 31, 2023 | USD 1.31 | 1.38% |
|
China |
|
38 |
13.60%
|
Dec. 31, 2023 | USD 3.31 | 1.64% |
|
China |
|
39 |
13.56%
|
Dec. 31, 2023 | USD 2.85 | 1.73% |
|
China |
|
40 |
13.37%
|
Dec. 31, 2023 | USD 4.00 | -0.23% |
|
China |
|
41 |
11.98%
|
Dec. 31, 2023 | USD 1.63 | -0.18% |
|
China |
|
42 |
11.82%
|
Dec. 31, 2023 | USD 0.30 | -0.45% |
|
China |
|
43 |
11.79%
|
Dec. 31, 2023 | USD 6.08 | 0.75% |
|
China |
|
44 |
10.88%
|
Dec. 31, 2023 | USD 2.09 | 0.57% |
|
China |
|
45 |
10.78%
|
Dec. 31, 2023 | USD 0.74 | 1.80% |
|
China |
|
46 |
10.43%
|
Dec. 31, 2023 | USD 3.12 | -1.05% |
|
China |
|
47 |
8.08%
|
Dec. 31, 2023 | USD 5.28 | -0.15% |
|
China |
|
48 |
8.07%
|
Dec. 31, 2023 | USD 2.25 | -5.87% |
|
China |
|
49 |
7.97%
|
Dec. 31, 2023 | USD 1.44 | -2.25% |
|
China |
|
50 |
6.06%
|
Dec. 31, 2023 | USD 0.87 | 1.51% |
|
China |
The Vaccines company in China with the highest EBIT Margin is Akeso, Inc. (HKSE: 9926.HK) at 44.84%.
The Vaccines company in China with the lowest EBIT Margin is ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKSE: 1541.HK) at -97,910.62%.
The top 10 Vaccines companies in China by EBIT Margin are Akeso, Inc., Wuhan Keqian Biology Co.,Ltd, Sansure Biotech Inc., Hualan Biological Bacterin Inc., Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., Hualan Biological Engineering Inc., Hansoh Pharmaceutical Group Company Limited, Chengdu Kanghua Biological Products Co., Ltd., Hangzhou Tigermed Consulting Co., Ltd. and Beijing Tiantan Biological Products Co., Ltd..
The bottom 10 Vaccines companies in China by EBIT Margin are ImmuneOnco Biopharmaceuticals (Shanghai) Inc., I-Mab, Mabwell (Shanghai) Bioscience Co., Ltd., CanSino Biologics Inc., Jacobio Pharmaceuticals Group Co., Ltd., Ascentage Pharma Group International, Ascletis Pharma Inc., AIM Vaccine Co., Ltd., Shanghai Junshi Biosciences Co., Ltd. and Zai Lab Limited.